Nicki Vasquez

Company: Sutro Biopharma

Job title: Chief Portfolio Strategy & Alliance Officer

Seminars:

Therapeutic Index Improvements of ADCs: What Are the Next Breakthroughs? 1:20 pm

Discussing the impact of ADC design on anti-tumor activity and platform adverse events Clinical liabilities of Exatecan/Top1 based ADCs and mitigation strategies Dual payload conjugates: same or better than chemo combos?Read more

day: Day Two - PM

Effectively & Efficiently Structuring Deal Processes as a Small ADC or Radiopharmaceutical Company 1:40 pm

Discussing the panel’s experiences executing and performing due diligence for noteworthy ADC and radiopharma, mergers, and licensing deals Sharing pharma’s expectation for data packages and deal process; how to differentiate in the buy/sell dynamic Outlining creative partnerships and deal structures that create effective BD&L in 2024Read more

day: Day Two - PM